Skip to main content
LENZ logo

LENZ · LENZ Therapeutics, Inc. · Analyst Estimates

Track LENZ — free
$4.10 -0.04 (-0.85%)
Market Cap
$140.45M
Shares
31.42M

Analyst Estimates

Compare analyst forecasts for LENZ Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 06:34 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-4.55
-4.245
-3.83
-4.57096
-4.56096
-4.56382
-4.56096
EPS
analysts
Publication date not stated
6
2
2
4
4
Revenue
USD
Publication date not stated
13682410
16989720
20700000
Revenue
analysts
Publication date not stated
7

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-4.35
-3.075
-2.35
-3.50704
-3.46847
-3.50704
-3.46847
EPS
analysts
Publication date not stated
6
3
3
2
2
Revenue
USD
Publication date not stated
28000000
42990570
75000000
Revenue
analysts
Publication date not stated
7

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.07
-0.97667
-0.85
-0.95179
-1.01868
-0.94179
-1.01868
EPS
analysts
Publication date not stated
6
3
3
4
3
Revenue
USD
Publication date not stated
2200000
4486730
9200000
Revenue
analysts
Publication date not stated
7

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.24
-0.92833
-0.64
-1.00347
-1.06726
-1.00181
-1.06726
EPS
analysts
Publication date not stated
6
2
2
3
2
Revenue
USD
Publication date not stated
3573000
5157570
8100000
Revenue
analysts
Publication date not stated
7
Key facts CIK 1815776 CUSIP 52635N103 13F (30d) 7 filings 6 filers Visit website Investor relations